Bio-Gene and STK Agree Binding Terms on Global Collaboration

"STK applies advanced botanical science and bio-ag technology in the development and commercialization of botanical crop protection solutions for growers worldwide and has operations and product registrations in more than 30 countries."

"Under the proposed agreement, STK intends to fully fund registration costs relating to the Qcide Active Ingredient. This will include required efficacy and toxicology studies, field trials, the generation of manufacturing data, and preparation of the regulatory submission. While STK would have ownership of the resulting registration, Bio-Gene will continue to own the IP relating to Qcide. Bio-Gene has unlimited access to the registration and can work with other commercial partners to develop and commercialize products in all market segments, including those licensed to STK on a non-exclusive basis."

---------------------------------------------

Disc:

Held IRL.